Literature DB >> 2497752

Secretion of cholesteryl ester transfer protein-lipoprotein complexes by human HepG2 hepatocytes.

R A Faust1, M C Cheung, J J Albers.   

Abstract

We have employed immunoaffinity chromatography to characterize the distribution of cholesteryl ester transfer activity in particles secreted by HepG2 hepatocytes. HepG2-secreted cholesteryl ester transfer activity is associated with apoprotein (apo) A-I (58%) as well as apo A-II (55%), and is not associated with apo B or E. In contrast, our previous studies have shown that most (88%) cholesteryl ester transfer activity in human plasma is associated with apo A-I whereas very little (7%) is associated with apo A-II. Thus, the distribution of cholesteryl ester transfer activity in plasma particles likely reflects active remodeling of nascent particles in the plasma compartment. Further data suggested that HepG2 cells secrete a lipid transfer inhibitor activity which is associated with apo E-containing lipoprotein particles. This inhibitory activity is heat labile.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2497752     DOI: 10.1016/0021-9150(89)90012-9

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  3 in total

1.  A multivariate method for detecting genetic linkage, with application to a pedigree with an adverse lipoprotein phenotype.

Authors:  C I Amos; R C Elston; G E Bonney; B J Keats; G S Berenson
Journal:  Am J Hum Genet       Date:  1990-08       Impact factor: 11.025

2.  Astroglial localization of cholesteryl ester transfer protein in normal and Alzheimer's disease brain tissues.

Authors:  T Yamada; M Kawata; H Arai; M Fukasawa; K Inoue; T Sato
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

3.  Pathways for the mutagenesis of 1-nitropyrene and dinitropyrenes in the human hepatoma cell line HepG2.

Authors:  K J Silvers; E P Eddy; E C McCoy; H S Rosenkranz; P C Howard
Journal:  Environ Health Perspect       Date:  1994-10       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.